The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APP(swe) Cell Model of AD

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that has proved refractory to drug treatment. Given evidence of neuroprotection in animal models of ischemic stroke, we assessed the prenylflavonoid xanthohumol from the Common Hop (Humulus lupulus L.) for therapeutic potential in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Huang, Xianfeng, Wang, Jing, Chen, Xiao, Liu, Pan, Wang, Shujin, Song, Fangchen, Zhang, Zaijun, Zhu, Feiqi, Huang, Xinfeng, Liu, Jianjun, Song, Guoqiang, Spencer, Peter S., Yang, Xifei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893754/
https://ncbi.nlm.nih.gov/pubmed/29670521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00199
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller